Clinical Application of Statins in Hospital Drug Cost Accounting
Statins are first-line lipid-lowering drugs and preventive drugs for cardiovascular diseases, and their clinical applications and research scopes are constantly expanding. Statins inhibit the HMG-CoA reductase, reduce the synthesis of endogenous cholesterol, and compensate the increase of liver low-density lipoprotein receptor expression, which increases the liver's ability to clear lipoproteins, thereby achieving lipid-lowering effects. This article analyzes the clinical application of statins in hospital drug costing. With the continuous deepening of the reform of the medical and health system, hospitals must continue to improve internal operations, strengthen refined management, and improve the cost responsibility system. Deepening hospital cost accounting and strengthening cost management and control is not only the need to deepen the reform, but also an important basis for establishing a modern hospital management system. Drug revenue is an important part of the hospital's medical business revenue, and drug costs are also a major component of the hospital's operating costs. Strengthening its management and accounting, medical safety, asset safety, cost control, and reducing patient burden on the hospital very important role.